$0.8430
-0.042-4.75%
Last update: Nov 10, 7:15 AM
Radiopharm Theranostics Ltd
RADXNASDAQ
The average analyst price target for Radiopharm Theranostics is $15.50, 1687.2% above the current price. Of 4 analysts, 4 rate it Buy. Targets range from $12 to $18. The latest change came on Jun 4, 2026, when HC Wainwright & Co. initiated coverage of Radiopharm Theranostics with a Buy rating and a $16 price target.
Price Target Range — 5 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months
